0      0

Outsourcing Medical Device Trials: FDA & Industry Perspective

Apr 25, 2010 10:00am ‐ Apr 25, 2010 11:00am

Credits: None available.


US medical device companies outsource 40% of their clinical trials and that number is expected to increase. Given this trend, it is essential that both industry and the regulator understand the nature of their symbiotic relationships. This session will cover strategies that may strengthen their relationship as well as pitfalls that may weaken it.



Credits: None available.

You must be logged in and own this session in order to post comments.